Cardiovascular Renal Metabolic

Broadcast

Cardiovascular Renal Metabolic

Heart Failure
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy

James Burton, Clara Bonanad Lozano , Aaron Wong, et al

ERA 25: Albuminuria, eGFR Dip and Disease Severity & Empagliflozin

William Herrington

Watch time: 3m 10s
ERA 25: Treating Obesity in 2025 and Beyond

Ruben Nogueiras

Watch time: 4m 16s
ERA 25: Switching from sMRAs to Finerenone

Beatriz Fernandez Fernandez

Watch time: 10m 48s
ERA 25: Survival Benefit in Deceased Donor Kidney Transplantation

Rachel Hellemans, Vianda Stel

Watch time: 5m 27s
ERA 25: eGFR Dips and Disease Severity on Empagliflozin

Watch time: 2m 52s
ERA 25: Highlights with Dr Kywe Kywe Soe

Watch time: 1m 45s
ERA 25: Highlights with Dr Johannes Stegbauer

Johannes Stegbauer

Watch time: 5m 36s
ERA 25: Guideline-Based Management of CKD

Ellen Linnea Freese Ballegaard

Watch time: 3m 13s
Real-World Data for CV and Renal Outcomes in DKD

David Wheeler

Watch time: 2m 39s

Paola Fioretto, Rajiv Agarwal

Watch time: 28m 13s (3 videos)

William Herrington

Watch time: 3m 10s (9 videos)

David Wheeler, Carol Pollock,

Muthiah Vaduganathan

Sydney Tang , ,

Lee Kaplan, Fatima Cody Stanford, Filip Knop, et al

Clara Bonanad Lozano , Anjay Rastogi

Andrew JS Coats, Stefan Anker

Tina Vilsbøll, Neha Pagidipati, Linda Mellbin, et al

Watch time: 2h (19 videos)

David K Ryan, Debasish Banerjee, Fadi Jouhra

Read time: 10m
Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus, , et al

Giulio Balestrieri, Raul Limonta, Enrico Ponti, et al

Read time: 18m 10s

Media

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
KDIGO GEMs - Glomerular Diseases

Brad Rovin, Jürgen Floege, Silke Brix, et al

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus, , et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Tina Vilsbøll, Neha Pagidipati, Linda Mellbin, et al

Watch time: 2h (19 videos)

Media

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
The Rise of CVRM Medicine: Managing Common Co-morbidities as One

Neha Pagidipati, Carel Le Roux, Lawrence A Leiter, et al

Broadcast

Cardiovascular Renal Metabolic

Heart Failure
Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy

James Burton, Clara Bonanad Lozano , Aaron Wong, et al

ESC HF 25: The PRAISE-HFrEF Study

Varun Sundaram

Watch time: 4m 10s

William Herrington

Watch time: 3m 10s (9 videos)
ERA 25: Albuminuria, eGFR Dip and Disease Severity & Empagliflozin

William Herrington

Watch time: 3m 10s
ERA 25: Survival Benefit in Deceased Donor Kidney Transplantation

Rachel Hellemans, Vianda Stel

Watch time: 5m 27s
Kidney Function Trajectories Before and After HF Hospitalisation

Nicolas Girerd

Watch time: 4m 39s
Liver Stiffness to Assess Central Venous Pressure in HF

Nicolas Girerd

Watch time: 2m 40s

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Advancements in Obesity Management (AOM) 2025

Harold Bays, Naveed Sattar, Liesbeth van Rossum, et al

Paola Fioretto, Rajiv Agarwal

Watch time: 28m 13s (3 videos)
ERA 25: Switching from sMRAs to Finerenone

Beatriz Fernandez Fernandez

Watch time: 10m 48s
ERA 25: Treating Obesity in 2025 and Beyond

Ruben Nogueiras

Watch time: 4m 16s

Articles

Obesity in Asia-Pacific

David Tak Wai Lui

,

Junya Ako

,

Jamshed Dalal

,

Alan Fong

,

Masashi Fujino

,

Ari Horton

,

Rungroj Krittayaphong

,

Wael Almahmeed

,

Anne Thushara Matthias

,

Adam J Nelson

,

Stephen Nicholls

,

Richard O’Brien

,

Kian Keong Poh

,

Khalida Soomro

,

Khung Keong Yeo

,

Kathryn Choon Beng Tan

,

Published:

05 June 2024

Citation:

Journal of Asian Pacific Society of Cardiology 2024;3:e21.

DOI:

https://doi.org/10.15420/japsc.2023.68
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 10440
  • Downloads: Downloads 101
  • Citations: 9
  • Read time: 20m 26s

Link Between NAFLD/NASH and Cardiometabolic Syndrome

Sheila Gato

,

Vanessa García-Fernández

,

Antonio Gil-Gómez

,

Ángela Rojas

,

Rocío Montero-Vallejo

,

Rocío Muñoz-Hernández

,

Manuel Romero-Gómez

,

Published:

09 May 2024

Citation:

European Cardiology Review 2024;19:e03.

DOI:

https://doi.org/10.15420/ecr.2023.26
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 960
  • Downloads: Downloads 54
  • Citations: 3
  • Read time: 20m 25s

Cardiovascular Risk in NAFLD

Paula Luque-Linero

,

Jose M Guerra

,

Published:

09 May 2024

Citation:

European Cardiology Review 2024;19:e02.

DOI:

https://doi.org/10.15420/ecr.2023.19
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1456
  • Downloads: Downloads 59
  • Citations: 1
  • Read time: 20m 54s

New Insights on HFpEF Treatment

Giulio Balestrieri

,

Raul Limonta

,

Enrico Ponti

,

Anna Merlo

,

Edoardo Sciatti

,

Salvatore D’Isa

,

Mauro Gori

,

Gavino Casu

,

Cristina Giannattasio

,

Michele Senni

,

Emilia D’Elia

,

Published:

03 April 2024

Citation:

Cardiac Failure Review 2024;10:e05.

DOI:

https://doi.org/10.15420/cfr.2023.13
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 12873
  • Downloads: Downloads 935
  • Citations: 3
  • Read time: 18m 10s